1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: August 24-30, 2025
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: August 24-30, 2025

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Martin A. Makary, M.D., M.P.H., Commissioner for Food and Drugs

Event Date: 08/25/2025
Location: Silver Spring, MD
Subject: Emerging Health Technology 
FDA Participant/Group: SARA BRENNER; JEREMY WALSH; 
Non FDA Participant/Group: Kerrianne Haresign, René Quashie (Consumer Technology Association);

Event Date: 08/25/2025
Location: Virtual
Subject: Innovations
FDA Participant/Group: GRACE GRAHAM; 
Non FDA Participant/Group: Senator John Hoeven (R-ND)

Event Date: 08/26/2025
Location: Silver Spring, MD
Subject: Advancing the Use of Real-World Data and Evidence (RWD/E) and Modernizing Regulatory Decision Making
FDA Participant/Group: GRACE GRAHAM; GEORGE TIDMARSH; LOWELL ZETA; 
Non FDA Participant/Group: Alyce Kuklinski, Deepen Gagneja, Emilie Scherrer, Grace Hsu, Jaclyn Bosco, Joe Franklin, Jonathan Kish, Lowell Schiller, Ryan Moog (The Real-World Evidence Alliance);

Event Date: 08/26/2025
Location: Silver Spring, MD
Subject: Streamlining the Federal Regulation Process
FDA Participant/Group: MICHELLE TARVER; SARA BRENNER; 
Non FDA Participant/Group: Donald S. Karcher, Gregary Bocsi, Han Tran, Joe Saad, Kristin L. McDonald, Qihui "Jim" Zhai (College of American Pathologists);

Event Date: 08/27/2025
Location: Washington, DC
Subject: Improving FDA-Related Disclosures in Public Company Filings
FDA Participant/Group: SEAN KEVENEY; JAMES TRAFICANT; 
Non FDA Participant/Group: Charles Lee, Paul Atkins (Securities and Exchange Commission (SEC));

Event Date: 08/28/2025
Location: Silver Spring, MD
Subject: Trial Design Considerations
FDA Participant/Group: VINAYAK PRASAD; LALEH AMIRI KORDESTANI; GEORGE TIDMARSH; SAMUEL DORAN; 
Non FDA Participant/Group: Charlie Garlisi, Christopher Pieczonka, Patrick Soon-Shiong, Richard Adcock (ImmunityBio);

Event Date: 08/29/2025
Location: Virtual
Subject: Kratom and 7-OH
FDA Participant/Group: NICHOLAS ALEXANDER; GRACE GRAHAM; LOWELL ZETA; 
Non FDA Participant/Group: Governor Mike DeWine (R-OH)

Official Name: Sara Brenner, M.D., M.P.H., Principal Deputy Commissioner for Food and Drugs

No Significant Event

Official Name: Sean R. Keveney, Chief Counsel

No Significant Event

Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Kyle Diamantas, J.D., Deputy Commissioner for Human Foods

Event Date: 08/25/2025
Location: Virtual
Subject: Good Agricultural Practices Program
FDA Participant/Group: SAMIR ASSAR; CONRAD CHOINIERE; DONALD PRATER; ERIK METTLER; 
Non FDA Participant/Group: Representatives from the National Association of State Departments of Agriculture, West Virginia Department of Agriculture, and the Virginia Department of Agriculture and Consumer Services

Event Date: 08/26/2025
Location: Ashland, VA 
Subject: Facility Visit: Food Traceability 
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from Wegmans Food Markets Inc. and the Food Industry Association

Event Date: 08/27/2025
Location: Virtual
Subject: Introductory and Food Traceability 
FDA Participant/Group: DONALD PRATER; 
Non FDA Participant/Group: Mala Parker, Mark Allen (International Foodservice Distributors Association);

Official Name: Barclay Butler, Ph.D., Deputy Commissioner for Operations

No Significant Event

Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives

Event Date: 08/27/2025
Location: Washington, DC
Subject: Reagan-Udall Foundation Public Meeting on Demand Forecasting for Controlled Substances; Speaker: Opening Remarks
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees

Official Name: Elizabeth Miller, Pharm.D., Acting Associate Commissioner for Inspections and Investigations

No Significant Event

Official Name: Vinayak Prasad, M.D., M.P.H., Director, Center for Biologics and Research

No Significant Event

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health

Event Date: 08/28/2025
Location: Silver Spring, MD
Subject: General Medical Device Updates
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Johnson and Johnson representatives

Official Name: George F. Tidmarsh, M.D., Ph.D., Director, Center for Drug Evaluation and Research

Event Date: 08/26/2025
Location: Silver Spring, MD
Subject: Procurement Consolidation and Market Prioritizations
FDA Participant/Group: N/A
Non FDA Participant/Group: David Light, Jill Nailor (Valisure);

Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products

No Significant Event

Official Name: Timothy Schell, Ph.D., Acting Director, Center for Veterinary Medicine

Event Date: 08/28/2025
Location: Washington, DC
Subject: Codex Policy Committee Meeting 
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, and other registered attendees

Back to Top